Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.
2.

[HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): a comparative study with fluorescent in situ hybridization (FISH)].

Akhdar A, Bronsard M, Lemieux R, Geha S.

Ann Pathol. 2011 Dec;31(6):472-9. doi: 10.1016/j.annpat.2011.10.013. Epub 2011 Nov 26. Review. French.

PMID:
22172120
3.

Emerging technologies for assessing HER2 amplification.

Penault-Llorca F, Bilous M, Dowsett M, Hanna W, Osamura RY, Rüschoff J, van de Vijver M.

Am J Clin Pathol. 2009 Oct;132(4):539-48. doi: 10.1309/AJCPV2I0HGPMGBSQ. Review.

PMID:
19762531
4.

[HER2 gene amplification assay: is CISH an alternative to FISH?].

Denoux Y, Arnould L, Fiche M, Lannes B, Couturier J, Vincent-Salomon A, Penault-Llorca F, Antoine M, Balaton A, Baranzelli MC, Becette V, Bellocq JP, Bibeau F, Ettore F, Fridman V, Gnassia JP, Jacquemier J, MacGrogan G, Mathieu MC, Migeon C, Rigaud C, Roger P, Sigal-Zafrani B, Simony-Lafontaine J, Trassard M, Treilleux I, Verriele V, Voigt JJ; Groupe d'Etude des Facteurs Pronostiques en Immunohistochimie dans le Cancer du Sein.

Ann Pathol. 2003 Dec;23(6):617-22. Review. French.

PMID:
15094603
5.

Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas.

Rosa FE, Santos RM, Rogatto SR, Domingues MA.

Braz J Med Biol Res. 2013 Mar;46(3):207-16. Epub 2013 Mar 19. Review.

6.

HER2 assessment by silver in situ hybridization: where are we now?

Sanguedolce F, Bufo P.

Expert Rev Mol Diagn. 2015 Mar;15(3):385-98. doi: 10.1586/14737159.2015.992416. Epub 2015 Jan 12. Review.

PMID:
25578771
7.

A Comparison of IHC and FISH Cytogenetic Methods in the Evaluation of HER2 Status in Breast Cancer.

Wesoła M, Jeleń M.

Adv Clin Exp Med. 2015 Sep-Oct;24(5):899-903. doi: 10.17219/acem/27923. Review.

8.

[Human epidermal growth factor receptor 2 testing in breast cancer].

Ivković-Kapicl T, Knezević-Usaj S.

Med Pregl. 2010 Jan-Feb;63(1-2):69-74. Review. Serbian.

PMID:
20873313
9.

Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma.

Gruver AM, Peerwani Z, Tubbs RR.

J Clin Pathol. 2010 Mar;63(3):210-9. doi: 10.1136/jcp.2009.062760. Review.

10.

Current technologies for HER2 testing in breast cancer.

Moelans CB, de Weger RA, Van der Wall E, van Diest PJ.

Crit Rev Oncol Hematol. 2011 Dec;80(3):380-92. doi: 10.1016/j.critrevonc.2010.12.005. Epub 2011 Jan 26. Review.

PMID:
21273092
12.

Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology.

Fuller CE, Perry A.

Brain Pathol. 2002 Jan;12(1):67-86. Review.

PMID:
11770903
13.

HER2/neu, Topoisomerase 2a, Estrogen and Progesterone Receptors: Discordance between Primary Breast Cancer and Metastatic Axillary Lymph Node in Expression and Amplification Characteristics.

Ataseven B, Gologan D, Gunesch A, Kehl V, Hoegel B, Beer M, Eiermann W.

Breast Care (Basel). 2012 Dec;7(6):465-70. doi: 10.1159/000345467. Review.

14.

Chemiluminescence: a sensitive detection system in in situ hybridization.

Musiani M, Pasini P, Zerbini M, Roda A, Gentilomi G, Gallinella G, Venturoli S, Manaresi E.

Histol Histopathol. 1998 Jan;13(1):243-8. Review.

PMID:
9476653
15.

[Bright field in-situ hybridization for delineation of HER2 status in breast cancer].

Li X, Yang X, Zhang W, Yang M, Huang LP.

Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):358-60. Review. Chinese. No abstract available.

PMID:
21756839
16.

[Companion diagnostics in the era of personalized medicine--chairmen's introductory remarks].

Fukutsuka K, Takubo T.

Rinsho Byori. 2014 Apr;62(4):378-80. Review. Japanese.

PMID:
25022067
17.
18.

In situ hybridization to human chromosomes of an alkaline phosphatase-labeled centromeric probe.

Nardone RM.

Methods Mol Biol. 1999;115:365-70. Review. No abstract available.

PMID:
10098204
19.

Bright-field microscopic detection of oligonucleotide PRINS-labeled DNA in chromosome preparations.

Speel EJ, Lawson D, Ramaekers FC, Gosden JR, Hopman AH.

Methods Mol Biol. 1997;71:13-22. Review. No abstract available.

PMID:
8959685

Supplemental Content

Support Center